FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.3401
-0.0001 (-0.03%)
At close: Mar 12, 2026, 4:00 PM EDT
0.3448
+0.0047 (1.38%)
After-hours: Mar 12, 2026, 5:18 PM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $22.99 million as of March 12, 2026. Its market cap has decreased by -45.71% in one year.
Market Cap
22.99M
Enterprise Value
20.50M
1-Year Change
-45.71%
Ranking
Category
Stock Price
$0.34
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $22.99M, a decrease of -97.57%. That is a compound annual growth rate of -82.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 22.99M | 53.67% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tevogen Bio Holdings | 25.83M |
| Neuphoria Therapeutics | 25.45M |
| Boundless Bio | 25.32M |
| NanoViricides | 25.05M |
| Vistagen Therapeutics | 24.99M |
| Barinthus Biotherapeutics | 24.50M |
| Polyrizon | 24.37M |
| Skye Bioscience | 22.66M |